At RSNA 2013, GE Healthcare introduced the Discovery Interventional Guidance System (IGS) 740, a 510(k)-pending mobile X-ray angiography system with a 41 x 41 cm detector. The system is aimed at interventional radiology market.
Omission of radiotherapy is a reasonable option for women age 65 and older who receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer, according to results of the PRIME 2 trial presented Dec. 11 at the 2013 San Antonio Breast Cancer Symposium.
If you enjoy this content, please share it with a colleague
The American College of Radiology (ACR) selected Claron’s NilRead zero-footprint diagnostic viewer for the communication of images and related data to support several new research and educational programs.